Richard Newitter
Stock Analyst at Truist Securities
(4.48)
# 237
Out of 4,832 analysts
362
Total ratings
53.79%
Success rate
18.33%
Average return
Main Sectors:
Stocks Rated by Richard Newitter
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GMED Globus Medical | Maintains: Hold | $80 → $68 | $58.17 | +16.90% | 27 | May 12, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $127 → $117 | $78.85 | +48.38% | 18 | May 8, 2025 | |
| TFX Teleflex | Maintains: Hold | $140 → $137 | $125.42 | +9.23% | 38 | May 5, 2025 | |
| SYK Stryker | Maintains: Hold | $390 → $400 | $386.32 | +3.54% | 20 | May 5, 2025 | |
| GKOS Glaukos | Reiterates: Buy | $140 → $135 | $91.57 | +47.43% | 5 | May 1, 2025 | |
| ITGR Integer Holdings | Maintains: Buy | $140 → $150 | $119.55 | +25.47% | 7 | Apr 28, 2025 | |
| BSX Boston Scientific | Maintains: Buy | $113 → $117 | $102.95 | +13.65% | 12 | Apr 24, 2025 | |
| ISRG Intuitive Surgical | Maintains: Buy | $605 → $590 | $565.94 | +4.25% | 28 | Apr 23, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $90 → $70 | $54.77 | +27.81% | 14 | Apr 11, 2025 | |
| VCEL Vericel | Maintains: Buy | $61 → $51 | $42.29 | +20.60% | 3 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $9.5 → $8 | $6.71 | +19.23% | 14 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $93 → $90 | $84.25 | +6.82% | 15 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $24 | $23.05 | +4.12% | 10 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $26 → $19 | $12.93 | +46.95% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $78 → $75 | $76.75 | -2.28% | 18 | Apr 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $111 → $145 | $140.41 | +3.27% | 16 | Feb 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $250 → $235 | $155.70 | +50.94% | 24 | Feb 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Hold | $118 → $113 | $95.33 | +18.54% | 32 | Feb 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $240 → $285 | $288.97 | -1.37% | 5 | Dec 18, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $17 → $21 | $18.73 | +12.12% | 1 | Jan 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $13.24 | +51.06% | 1 | Aug 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $71 → $82 | $87.24 | -6.01% | 5 | Aug 19, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Market Perform | $260 → $250 | $171.02 | +46.18% | 5 | Aug 6, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $27 → $26 | $3.02 | +762.35% | 4 | May 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $690 → $770 | $187.65 | +310.34% | 10 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $94 → $85 | $55.35 | +53.58% | 6 | Apr 29, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $20 | $14.18 | +41.04% | 1 | Feb 24, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $23 → $27 | $11.83 | +128.23% | 5 | Feb 23, 2021 |
Globus Medical
May 12, 2025
Maintains: Hold
Price Target: $80 → $68
Current: $58.17
Upside: +16.90%
Lantheus Holdings
May 8, 2025
Maintains: Buy
Price Target: $127 → $117
Current: $78.85
Upside: +48.38%
Teleflex
May 5, 2025
Maintains: Hold
Price Target: $140 → $137
Current: $125.42
Upside: +9.23%
Stryker
May 5, 2025
Maintains: Hold
Price Target: $390 → $400
Current: $386.32
Upside: +3.54%
Glaukos
May 1, 2025
Reiterates: Buy
Price Target: $140 → $135
Current: $91.57
Upside: +47.43%
Integer Holdings
Apr 28, 2025
Maintains: Buy
Price Target: $140 → $150
Current: $119.55
Upside: +25.47%
Boston Scientific
Apr 24, 2025
Maintains: Buy
Price Target: $113 → $117
Current: $102.95
Upside: +13.65%
Intuitive Surgical
Apr 23, 2025
Maintains: Buy
Price Target: $605 → $590
Current: $565.94
Upside: +4.25%
PROCEPT BioRobotics
Apr 11, 2025
Maintains: Buy
Price Target: $90 → $70
Current: $54.77
Upside: +27.81%
Vericel
Apr 11, 2025
Maintains: Buy
Price Target: $61 → $51
Current: $42.29
Upside: +20.60%
Apr 11, 2025
Maintains: Hold
Price Target: $9.5 → $8
Current: $6.71
Upside: +19.23%
Apr 11, 2025
Maintains: Hold
Price Target: $93 → $90
Current: $84.25
Upside: +6.82%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $24
Current: $23.05
Upside: +4.12%
Apr 11, 2025
Maintains: Hold
Price Target: $26 → $19
Current: $12.93
Upside: +46.95%
Apr 11, 2025
Maintains: Hold
Price Target: $78 → $75
Current: $76.75
Upside: -2.28%
Feb 21, 2025
Maintains: Buy
Price Target: $111 → $145
Current: $140.41
Upside: +3.27%
Feb 11, 2025
Maintains: Buy
Price Target: $250 → $235
Current: $155.70
Upside: +50.94%
Feb 10, 2025
Reiterates: Hold
Price Target: $118 → $113
Current: $95.33
Upside: +18.54%
Dec 18, 2024
Maintains: Buy
Price Target: $240 → $285
Current: $288.97
Upside: -1.37%
Jan 31, 2023
Maintains: Buy
Price Target: $17 → $21
Current: $18.73
Upside: +12.12%
Aug 24, 2021
Initiates: Outperform
Price Target: $20
Current: $13.24
Upside: +51.06%
Aug 19, 2021
Maintains: Market Perform
Price Target: $71 → $82
Current: $87.24
Upside: -6.01%
Aug 6, 2021
Maintains: Market Perform
Price Target: $260 → $250
Current: $171.02
Upside: +46.18%
May 11, 2021
Maintains: Outperform
Price Target: $27 → $26
Current: $3.02
Upside: +762.35%
Apr 29, 2021
Maintains: Outperform
Price Target: $690 → $770
Current: $187.65
Upside: +310.34%
Apr 29, 2021
Maintains: Outperform
Price Target: $94 → $85
Current: $55.35
Upside: +53.58%
Feb 24, 2021
Initiates: Outperform
Price Target: $20
Current: $14.18
Upside: +41.04%
Feb 23, 2021
Maintains: Outperform
Price Target: $23 → $27
Current: $11.83
Upside: +128.23%